Komori
Other Disclosures7780Menicon Co.,Ltd.Electrical Equipment and Precision Instruments

Notice of the Launch of “Sears,” an Ophthalmic Material for Maintaining a Clear Surgical Field

Menicon will begin selling “シアーズ®,” a medical device that limits blood flow during glaucoma surgery and improves visualization of the surgical site, on 18 May 2026.

Worth reading
51Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Announced details

Ophthalmic surgical visualization material “シアーズ®”
Applicable field (uses covered by this announcement)

Glaucoma surgery

Launch dateSales scheduled to begin on 18 May 2026

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Announced details
ItemDetails
Names of Products / Services CoveredOphthalmic surgical visualization material “シアーズ®”
Launch dateSales scheduled to begin on 18 May 2026
Applicable areaGlaucoma surgery
Items this document does not state (15)
CounterpartyCounterparty overviewRelationship with the CompanyContract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleQuantitative EffectsUsage historyImpact on Business PerformanceSource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The product is intended to limit blood flow into the surgical site during glaucoma surgery and ensure visualization of the surgical field. Its use is expected to make surgical procedures easier to perform and reduce the burden on physicians.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of the Launch of “Sears,” an Ophthalmic Material for Maintaining a Clear Surgical Field | Menicon Co.,Ltd. (7780) timely disclosure | Komori